- Haleon
- 28 March 2025 08:32:48
Source: Sharecast
The FTSE 100 consumer products giant said the initiative followed its £170m off-market share purchase from Pfizer earlier in the month.
It said the first tranche of the buyback would total up to £200m, and will run until no later than 26 June.
Shares repurchased under the tranche would be cancelled, reducing Haleon’s share capital.
The company said it expected the programme to enhance earnings per share, and align it with its broader capital allocation priorities including delivering shareholder returns.
Haleon said it had entered into an irrevocable agreement with Goldman Sachs International to execute the first tranche.
Goldman Sachs would carry out the purchases independently on the London Stock Exchange, including during any closed periods.
Further tranches would be announced in due course.
At 0815 GMT, shares in Haleon were up 0.81% at 385p.
Reporting by Josh White for Sharecast.com.